Longvida® Optimized Curcumin Found to Improve Cognitive Function and Mood

New Published Clinical Trial from Swinburne University’s Centre for Human Psychopharmacology

NOBLESVILLE, IN – Newly published data in the prestigious Journal of Psychopharmacology from a randomized, double-blind, placebo-controlled clinical trial shows that Longvida® Optimized Curcumin improves cognitive function and mood (1).

The study, performed at the Centre for Human Psychopharmacology at Swinburne University in Melbourne, Australia, and is one of the first to show curcumin can improve brain function in healthy older adults.

Authors stated: “…this is the first study to examine the effects of curcumin on cognition and mood in a healthy older population or to examine any acute behavioral effects in humans.”

One hour after treatment with a single 400mg capsule of Longvida, participants in the Longvida group showed superior performance over the placebo group on validated tasks relating to attention and working memory (p<0.05). In addition, 30-day supplementation improved measures of calmness, contentedness and fatigue versus placebo (p<0.05 and p<0.01). The study included 60 participants, and no dropouts or side effects were reported.

“Behavioral measures showed that even at the low dose implemented here (approximately 80 mg) curcumin has the potential to improve important cognitive functions, reduce fatigue and improve resilience to the detrimental effects of psychological stress on mood.”

The authors suggested a possible mechanism by which the effects of Longvida to support energy were observed:  “Curcumin may help to combat fatigue by improving the maintenance of energy levels and ability to meet energy demands through its effects on mitochondrial function, AMP-activated protein kinase and glucose uptake and regulation.”

The study was presented at the British Psychological Society’s Psychobiology Annual Scientific Meeting in September 2013, and is now published in the Journal of Psychopharmacology.

About Longvida®:

Longvida® Optimized Curcumin was developed by Verdure Sciences™ in collaboration with UCLA neuroscientists over ten years of bioavailability, efficacy, and safety testing. Longvida® has blazed new paths in brain research, supported by more than a dozen studies and clinical trials. At 65 times more bioavailable than regular curcumin, Longvida® is able to reach its target tissues to offer therapeutic levels of free curcumin at a low daily dose.

About Verdure Sciences™:
Verdure Sciences manages ingredient innovation throughout the integration of supply network, production and research platforms. With an expanding pipeline of proprietary, standardized botanical ingredients supported by pharmacokinetic, pharmacodynamic, and clinical research profiles, we work toward our unified vision to offer access to safe, effective ingredient solutions to populations worldwide.

References:

1. Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. Cox et al 2014, Journal of Psychopharmacology, in publication.

^† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Longvida is a registered trademark of Verdure Sciences Inc. covered under Patent EP 1993365, additional patents pending. SLP and Verdure Sciences are trademarks of Verdure Sciences Inc. All Rights Reserved. ©2014 Verdure Sciences.